Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00192439 · ClinicalTrials.gov registry record
Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk
A clinical trial of Severe Respiratory Disease, sponsored by MedImmune.
- Completed
- Registry status
- 1,500
- Enrollment target
- 20
- Study locations
NCT00192439: Completed study of Severe Respiratory Disease, sponsored by MedImmune.
NCT00192439 is a study of Severe Respiratory Disease that has completed, run by MedImmune. The registered enrollment target is 1,500 participants. The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00192439, a study of Severe Respiratory Disease, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
\- Estimate the incidence rate of hMPV infection detected by RT-PCR from frozen nasal wash aspirates in children at high risk for severe LRI disease (hospitalized at \<2 years of age).
Conditions Studied
Interventions
- BEHAVIORAL High Risk Respiratory Disease
Study Locations (20)
New York
- The Children's Hospital - Buffalo
- Schneider Children's Hospital, Long Island Jewish Medical Center - New Hyde Park
- Univ. of Rochester Medical Center - Rochester
- Suny Upstate Medical Univ. - Syracuse
North Carolina
- Duke University Medical Center - Durham
- Wake Forest Univ. School of Medicine - Winston-Salem
Texas
- Univ. of Texas Southwestern Medical Center - Dallas
- Baylor College of Medicine - Houston
California
- Miller Children's Hospital - Long Beach
Colorado
- The Children's Hospital - Denver
Illinois
- Children's Memorial Hospital - Chicago
Massachusetts
- New England Medical Center - Boston
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2003-12 |
| Est. Completion | 2006-12 |
What the finished NCT00192439 record still lists
NCT00192439 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Severe Respiratory Disease appearing as the primary indexed condition, and to 1 intervention - of which High Risk Respiratory Disease is the first listed.
NCT00192439 names 20 study sites across 15 states, led by New York, North Carolina, Texas.
Frequently Asked Questions
What is clinical trial NCT00192439 about?
NCT00192439 is a clinical study titled "Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk". \- Estimate the incidence rate of hMPV infection detected by RT-PCR from frozen nasal wash aspirates in children at high risk for severe LRI disease (hospitalized at \<2 years of age).
What is the current status of trial NCT00192439?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2003-12. Estimated completion is 2006-12.
What conditions does trial NCT00192439 study?
This clinical trial studies the following conditions: Severe Respiratory Disease.
What interventions are being tested in trial NCT00192439?
The interventions under investigation include: High Risk Respiratory Disease (BEHAVIORAL).
Who is sponsoring clinical trial NCT00192439?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00192439 being conducted?
This trial has 20 study locations across California, Colorado, Illinois, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia